Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 25Burkitt Lymphoma 15Sarcoma 14Neoplasms 11Lymphoma, Follicular 11Lymphoma 11Hodgkin Disease 10Breast Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Non-Hodgkin 9Triple Negative Breast Neoplasms 8Ovarian Neoplasms 8Endometrial Neoplasms 8Lymphoma, B-Cell 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Recurrence 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm Metastasis 5Fallopian Tube Neoplasms 5Wilms Tumor 4Osteosarcoma 4Lymphoma, Mantle-Cell 4Liposarcoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Sarcoma, Ewing 3Neuroblastoma 3Lymphoproliferative Disorders 3Lymphoma, B-Cell, Marginal Zone 3Leukemia 3

Interventions

Watchful Waiting 1Vincristine 1Topotecan 1Specimen Handling 1Razoxane 1Observation 1Magnetic Resonance Spectroscopy 1Ifosfamide 1High-Energy Shock Waves 1Doxorubicin 1Dexrazoxane 1Dactinomycin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleuropulmonary blastoma × Doxorubicin × 90 days × Clear all
NCT06647953 2026-05-05

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Children's Oncology Group

Phase 3 Recruiting
110 enrolled

Pleuropulmonary blastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡